1. Maurer M, Magerl M, Betschel S, et al. The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update. Allergy 2022; 77: 1961-90.
2.
Rajan N, Sharma V, Patro SK, Goyal A. Acute presentation of undiagnosed hereditary angioedema of the larynx: averting death. Turk Arch Otorhinolaryngol 2020; 58: 279-81.
3.
Piotrowicz-Wójcik K, Porebski G. Life-threatening laryngeal attacks in hereditary angioedema patients. Otolaryngol Pol 2020; 74: 1-5.
4.
Moldovan D, Bara N, Nădășan V, et al. Consequences of misdiagnosed and mismanaged hereditary angioedema laryngeal attacks: an overview of cases from the Romanian Registry. Case Rep Emerg Med 2018; 2018: 6363787.
5.
Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol 2012; 130: 692-7.
6.
Patel G, Pongracic JA. Hereditary and acquired angioedema. Allergy Asthma Proc 2019; 40: 441-5.
7.
Maurer M, Aygören-Pürsün E, Banerji A, et al. Consensus on treatment goals in hereditary angioedema: a global Delphi initiative. J Allergy Clin Immunol 2021; 148: 1526-32.
8.
Caballero T, Maurer M, Longhurst HJ, et al.; IOS Study Group. Triggers and prodromal symptoms of angioedema attacks in patients with hereditary angioedema. J Investig Allergol Clin Immunol 2016; 26: 383-6.
9.
Longhurst H, Cicardi M. Hereditary angio-oedema. Lancet 2012; 379: 474-81.
10.
Bernstein JA. Update on angioedema: evaluation, diagnosis, and treatment. Allergy Asthma Proc 2011; 32: 408-12.
11.
Kemp JG, Craig TJ. Variability of prodromal signs and symptoms associated with hereditary angioedema attacks: a literature review. Allergy Asthma Proc 2009; 30: 493-9.
12.
Yong PFK, Guilarte M. Prodromal symptoms of hereditary angioedema (HAE) attacks: a patient survey in UK and Spain. Allergy 2024; 79: 2258-62.
13.
Leibovich-Nassi I, Reshef A, Somech R, Golander H. Prodromes as predictors of hereditary angioedema attacks. Allergy 2022; 77: 1309-12.
14.
Leibovich-Nassi I, Reshef A. The enigma of prodromes in hereditary angioedema (HAE). Clin Rev Allergy Immunol 2021; 61: 15-28.
15.
Zuraw BL, Christiansen SC. Hereditary angioedema and bradykinin-mediated angioedema. In: Adkinson NF Jr, Bochner BS, Burks AW, et al. (eds.). Middleton’s Allergy: Principles and Practice. Vol. 1. 8th ed. Elsevier Saunders, Philadelphia 2014; 588-601.
16.
Johnsrud I, Kulseth MA, Rødningen OK, et al. A nationwide study of norwegian patients with hereditary angioedema with C1 inhibitor deficiency identified six novel mutations in SERPING1. PLoS One 2015; 10: e0131637.
17.
Henao MP, Kraschnewski JL, Kelbel T, Craig TJ. Diagnosis and screening of patients with hereditary angioedema in primary care. Ther Clin Risk Manag 2016; 12: 701-11.
18.
Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006; 119: 267-74.
19.
Zanichelli A, Magerl M, Longhurst H, et al. Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe. Allergy Asthma Clin Immunol 2013; 9: 29.
20.
Zanichelli A, Magerl M, Longhurst HJ, et al.; IOS Study Group. Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey. Clin Transl Allergy 2018; 8: 42..
21.
Gehlen CT, Mazzeu JF, Veronez CL, et al. The burden of hereditary angioedema in a large family in Brazil. Int Arch Allergy Immunol 2024: 1-9. doi: 10.1159/000538518.
22.
Bernstein JA. Severity of hereditary angioedema, prevalence, and diagnostic considerations. Am J Manag Care 2018; 24 (14 Suppl): S292-8.
23.
Longhurst H, Bygum A. The humanistic, societal, and pharmaco-economic burden of angioedema. Clin Rev Allergy Immunol 2016; 51: 230-9.
24.
Busse PJ, Christiansen SC, Riedl MA, et al. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. J Allergy Clin Immunol Pract 2021; 9: 132-50.e3.
25.
Bork K, Hardt J, Staubach-Renz P, Witzke G. Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 112: 58-64.
26.
Valerieva A, Staevska M, Jesenak M, et al. Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema. J Allergy Clin Immunol Pract 2020; 8: 799-802.
27.
Longhurst HJ, Bork K. Hereditary angioedema: an update on causes, manifestations and treatment. Br J Hosp Med (Lond) 2019; 80: 391-8.
28.
Gazerani P. Pharmacophobia and pharmacophilia in analgesic use. Pain Manag 2017; 7: 341-4.
29.
Ruscher SM, deWit R, Mazmanian D. Psychiatric patients’ attitudes about medication and factors affecting noncompliance. Psychiatr Serv 1997; 48: 82-5.
30.
De Las Cuevas C, Peñate W. Explaining pharmacophobia and pharmacophilia in psychiatric patients: relationship with treatment adherence. Hum Psychopharmacol 2015; 30: 377-83.
31.
Sibitz I, Katschnig H, Goessler R, et al. Pharmacophilia and pharmacophobia: determinants of patients’ attitudes towards antipsychotic medication. Pharmacopsychiatry 2005; 38: 107-12.
